Financial Analysis: PowerFleet (NASDAQ:AIOT) and CryoPort (NASDAQ:CYRX)

PowerFleet (NASDAQ:AIOT) and CryoPort (NASDAQ:CYRX) are both small-cap transportation companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, valuation, earnings, analyst recommendations, profitability and dividends.

Profitability

This table compares PowerFleet and CryoPort’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PowerFleet	-7.00%	-5.23%	-2.61%
CryoPort	42.35%	-8.22%	-4.84%

Risk and Volatility

PowerFleet has a beta of 1.38, suggesting that its share price is 38% more volatile than the S&P 500. Comparatively, CryoPort has a beta of 1.75, suggesting that its share price is 75% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and target prices for PowerFleet and CryoPort, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PowerFleet	0	2	3	0	2.60
CryoPort	1	1	7	0	2.67

PowerFleet currently has a consensus price target of $11.50, indicating a potential upside of 252.76%. CryoPort has a consensus price target of $13.31, indicating a potential upside of 28.62%. Given PowerFleet’s higher probable upside, equities analysts clearly believe PowerFleet is more favorable than CryoPort.

Valuation & Earnings

This table compares PowerFleet and CryoPort”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PowerFleet	$362.52 million	1.21	-$50.99 million	($0.23)	-14.17
CryoPort	$176.18 million	2.95	$78.30 million	$1.32	7.84

CryoPort has lower revenue, but higher earnings than PowerFleet. PowerFleet is trading at a lower price-to-earnings ratio than CryoPort, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

73.4% of PowerFleet shares are owned by institutional investors. Comparatively, 92.9% of CryoPort shares are owned by institutional investors. 6.3% of PowerFleet shares are owned by company insiders. Comparatively, 10.1% of CryoPort shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

CryoPort beats PowerFleet on 10 of the 14 factors compared between the two stocks.

About PowerFleet

PowerFleet, Inc. engages in the provision of fleet management solutions for logistics, industrial, and vehicles. It offers wireless Internet of Things and machine to machine solutions for securing, controlling, tracking, and managing enterprise assets such as industrial trucks, tractor trailers, containers, cargo, and vehicle and truck fleets. It operates through the following geographical segments: United States, Israel, and Other. The company was founded in 1993 and is headquartered in Woodcliff Lake, NJ.

About CryoPort

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.